Evaluation of Serum Levels and Expression of Galectin-4 in Cervical Cancer

Table 1

Galectin-4 serum levels and clinic-pathological features of patients with CC.

Cervical cancer		Gal-4 in serum (pg/ml)		value
		Median	Range
Histological type
Squamous carcinoma	32	757.062	141.130-2518.000	0.0949
Adenocarcinoma	7	493.630	149.880-1388.000
Differentiation
Poor	6	539.285	316.430-1139.290
Moderate	21	565.000	149.880-1636.430	ns
Well	3	1108.000	368.630-2518.000
No reported	9
Keratinizing
No	14	630.030	141.130-1462.140	0.4677
Yes	10	757.062	381.130-1478.000
Not reported	15
FIGO staging
I-II	17	563.630	141.130-1462.140	0.1997
III-IV	10	681.992	453.630-1356.429
Not classifiable	12
Tumor size (cm)
≤5.1	8	613.155	198.630-1636.430	0.1325
>5.1	6	448.630	141.130-647.860
No size	24

values were calculated using Mann–Whitney test with the exception of the differentiation grade which was calculated using Kruskal-Wallis test.